Why Bigger Bottles Are Not Always Better
Bottle size is part of product design.
A larger bottle is not always a better product, and in hemp-derived cannabinoid products, package size can also be shaped by regulation, testing, and long-term product durability.
That is one reason we standardize around 30 mL bottles.
Bottle size is not just a marketing choice
When people compare cannabinoid products, it is easy to assume that a larger bottle is automatically a better value.
Sometimes it is. Sometimes it is not.
Bottle size affects more than price. It also affects:
- total cannabinoids per package
- how the product fits within the regulatory framework
- how clearly the product can be tested
- how likely the product is to remain durable as rules change
That is why bottle size is something we think about deliberately.
Why 30 mL is a practical standard
A 30 mL bottle is a straightforward format.
It is familiar, easy to compare, easy to dose, and practical from both a manufacturing and compliance standpoint.
It also gives us a standard package size across much of the product line, which makes comparison easier.
When customers compare products, it helps when the format is consistent.
Larger packages are not always better
A larger bottle can look appealing because it suggests more product in one package.
But once regulation starts focusing more heavily on per-package cannabinoid limits, larger packages become more complicated.
That is especially true for products that contain THC in defined amounts, but it also matters for isolate-based products if the goal is to prove that total THC per package remains below a very low threshold.
In other words, package size is not only about convenience. It is also about what can realistically be demonstrated through testing.
What LOQ means
LOQ stands for limit of quantitation.
That is the lowest level at which a lab can reliably measure a compound and report a number for it.
Why that matters: if a package has to stay below a very low total THC threshold, the lab’s LOQ has to be low enough to support that mathematically.
If the LOQ is too high, then a result reported as less than LOQ does not fully answer the package-level question.
Why testing sensitivity affects package size
As regulation evolves, per-package cannabinoid limits are likely to matter more.
In that environment, package size and testing sensitivity become directly connected.
A lab result reported as less than the limit of quantitation is only useful if the LOQ is low enough to support the package-level threshold mathematically.
As the package size increases, the required LOQ becomes smaller and smaller.
That makes larger packages harder to prove compliant when the goal is to stay below a very low cannabinoid threshold per package.
That is one reason we standardize around 30 mL bottles and build our isolate product line around formats that can be supported by real testing.
We are planning for future per-package limits
We are not only thinking about what works today.
We are also planning for what happens if future rules put more emphasis on cannabinoids per package rather than only concentration-based measurements.
If that happens, package size will matter even more than it already does.
Our goal is to keep products as available and consistent as possible over time. That means designing with future compliance in mind, not just current demand.
Why this matters for our isolate products
For isolate-based products, standardizing around 30 mL helps us work toward a more durable structure.
It gives us a package size that is practical for customers and also realistic from a testing and compliance standpoint.
That does not mean rules will never change. It means we are trying to build products that can continue to make sense even as the rules change around them.
Consistency matters too
Standardizing around 30 mL also makes product comparison simpler.
When products share the same basic bottle size, it becomes easier to compare:
- concentration
- total milligrams
- price per mg
- product type
That clarity matters.
We would rather make the structure easier to understand than chase larger package sizes that may not hold up well over time.
Why we do it this way
Our goal is not just to offer strong value today.
It is to build products that remain clear, consistent, and durable as the regulatory landscape evolves.
That is part of what we mean when we think about sustainable products and long-term availability.
This is a core principal of our Mission.
We want customers to be able to come back to a product line that is built with continuity in mind.
Our current product line
If you want to compare products directly, you can explore our current lineup, including:
- CBD Isolate Oil Drops
- CBG Isolate Oil Drops
- CBD+THC 100:1 Oil Drops
- CBD+THC 20:1 Oil Drops
- CBD Isolate Topical Salve - Unscented
- CBD+THC 20:1 Topical Salve - Natural Unscented
Our bottle sizes and package formats are chosen deliberately, with product clarity, practical dosing, and long-term durability in mind.